Company Data
REGENXBIO Inc.
Ticker
RGNX
Current Price
$9.3 7.02%
Market Cap
$470.8M
Price Target
Refer to Report
Volume
551.4K
52wk Range
$5.035 - $16.19
Overview
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno-associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa).